Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/19/25 16:59 | 12/17/25 | ELUT | Health | BioPrd | Biological Products, (No Diag | Rakin Kevin | CT | DT | 1 | P | 26 | 0.5199 | 0 | 50 | 1 | 5,155 | I | |||||||||||||||
12/18/25 09:00 | 12/17/25 | ELUT | Health | BioPrd | Biological Products, (No Diag | Colpman David | MD | D | 2 | P | 18 | 0.6373 | 0 | 28 | 904 | 31 | D | |||||||||||||||
12/18/25 09:00 | 12/17/25 | ELUT | Health | BioPrd | Biological Products, (No Diag | Makes Brigid | MD | D | 1 | P | 13 | 0.5200 | 0 | 25 | 999% | 27 | D | |||||||||||||||
12/18/25 09:00 | 12/17/25 | ELUT | Health | BioPrd | Biological Products, (No Diag | Mills C Randal | MD | DO | P,CEO | 4 | P.d | 15 | 0.3013 | 0 | 49 | 15 | 379 | D | ||||||||||||||
12/18/25 09:00 | 12/17/25 | ELUT | Health | BioPrd | Biological Products, (No Diag | Ferguson Matthew | MD | O | CFO | 3 | P.dm | 38 | 0.4656 | 0 | 83 | 23 | 447 | D | ||||||||||||||
12/12/25 17:00 | 12/10/25 | ELUT | Health | BioPrd | Biological Products, (No Diag | Williams Michelle Leroux | MD | O | CHIEF SC | 1 | M.d | 0 | 0.00 | 0 | 13 | 14 | 102 | D | ||||||||||||||
12/2/25 17:00 | 12/1/25 | ELUT | Health | BioPrd | Biological Products, (No Diag | Neels Guido J | MD | D | 1 | M.d | 0 | 0.00 | 0 | 6 | 10 | 69 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |